← Back to Search

Behavioral Intervention

Church-based Health Intervention for Cardiovascular Disease (CHERISH Trial)

N/A

Recruiting

Research Sponsored by Tulane University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Black or African American men or women aged ≥40 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6, 12, and 18 months

Awards & highlights

CHERISH Trial Summary

This trial studies the impact of two approaches to reduce CVD disparities in Black communities in Louisiana. One is a CHW-led multifaceted intervention, the other is a group-based education strategy.

Who is the study for?

The CHERISH study is for Black or African American adults aged 40 and over who are connected to participating churches in New Orleans. They must have at least four of these risk factors: smoking, obesity, low physical activity, poor diet, high cholesterol, high blood pressure, or elevated blood sugar. Those with recent severe health issues like cancer treatment or heart failure aren't eligible.Check my eligibility

What is being tested?

This trial tests two strategies to improve cardiovascular health in the Black community using guidelines from the ACC/AHA. One strategy involves a community health worker leading various interventions; the other uses group education. The study will last 18 months and measure how well each method works.See study design

What are the potential side effects?

Since this trial focuses on lifestyle changes and education rather than medication, side effects are not typical as seen with drug trials. However, participants may experience discomfort adjusting to new diets or exercise routines.

CHERISH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a Black or African American person aged 40 or older.

CHERISH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6, 12, and 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6, 12, and 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6, 12, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in change in estimated atherosclerotic cardiovascular disease (ASCVD) risk score

Fidelity summary score

Secondary outcome measures

Acceptability

Adoption (church)

Adoption (provider)

+19 more

Other outcome measures

Difference in medication adherence

Difference in proportion of those receiving statin treatment who are eligible

Difference in proportion of those who cease smoking of those who are current smokers at baseline

+1 more

CHERISH Trial Design

2Treatment groups

Experimental Treatment

Group I: Group-based Education StrategyExperimental Treatment1 Intervention

Group-based education sessions; information on primary care physicians; and instruction on self-monitoring of BP.

Group II: Community health worker-led implementation strategy:Experimental Treatment1 Intervention

Individual coaching sessions; healthcare navigation; healthcare at community settings; church-based nutrition education and exercise programs; and self-monitoring of BP.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,505,800 Total Patients Enrolled

Tulane UniversityLead Sponsor

115 Previous Clinical Trials

225,452 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the main goals of this experiment?

"This clinical trial is intended to evaluate the efficacy of a new intervention by measuring Fidelity summary score over an 18-month period. Secondary outcomes include difference in change in diastolic blood pressure, total cholesterol level, and low-density lipoprotein (LDL) cholesterol between the two arms."

Answered by AI

Is recruitment currently underway for the clinical trial?

"As per the clinicaltrials.gov records, this research is currently not recruiting patients. The trial was initially posted on November 18th 2023 and had its last update on September 26th of that year as well. Although this study does not have spots open at present, there are 1,376 other trials actively seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

2023. "Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06065098.

All > New Orleans > Cholesterol